Safety of multi-access site venous closure following catheter ablation of atrial fibrillation and flutter
- PMID: 38413483
- PMCID: PMC11379729
- DOI: 10.1007/s10840-024-01773-3
Safety of multi-access site venous closure following catheter ablation of atrial fibrillation and flutter
Abstract
Background: Following catheter ablation, vascular access management involves potential complications and prolonged recovery. Recently, suture-mediated closure (SMC) devices were approved for venous access procedures. The objective of this study is to evaluate the safety of a commercially available SMC for multiple access site venous closure by duplex ultrasound (DUS) in asymptomatic subjects with non-visible complications.
Methods: Thirty-six subjects (63 ± 10.7 years old, 12 female) were enrolled. Following catheter ablation for atrial fibrillation, all subjects had SMC of every venous access site. Subjects underwent DUS of femoral veins and arteries. DUS was performed at discharge, and again at 30 days. Subjects were evaluated for clinically apparent vascular complications.
Results: Mean procedure duration was 138.6 min, and the time to hemostasis was 3.1 min/access site and 9.5 min/subject. Median time to ambulation was 193.5 min, and median time to discharge was 5.95 h, with discharge as early as 2.4 h. A median of 2 sheaths/vein and a median of 2 SMC devices/vein were used. There were no major complications and a 16.7% (6/36) minor complication rate at discharge. All complications resolved at 30 days. The complication rate was not higher in patients with 2 SMC per access site as compared to the patients who just received 1 SMC per access site.
Conclusions: This study demonstrates the safety of multi-access closure using SMC, following catheter ablation procedures, for closure of sites that use sheath sizes from ≤ 8F to ≥ 15F and for those that use 2 or more SMCs per access site.
Keywords: Atrial fibrillation; Catheter ablation; Closure device; Duplex ultrasound.
© 2024. The Author(s).
Conflict of interest statement
Dr. Gupta consults for Medtronic, Boston Scientific, and Respicardia. Dr. Kolluri is the President of Syntropic Core Lab and has consulted for Abbott, Boston Scientific, Medtronic, and other companies. Drs. Pingle, Simoes, and Nie are Abbott employees. Dr. Kiani was a member of the Abbott Vascular Closure Advisory Board in 2021.
Figures
Similar articles
-
Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial.JACC Clin Electrophysiol. 2020 Jan;6(1):111-124. doi: 10.1016/j.jacep.2019.08.013. Epub 2019 Oct 30. JACC Clin Electrophysiol. 2020. PMID: 31971899 Clinical Trial.
-
Costs, efficiency, and patient-reported outcomes associated with suture-mediated percutaneous closure for atrial fibrillation ablation: Secondary analysis of a randomized clinical trial.J Cardiovasc Electrophysiol. 2024 Dec;35(12):2372-2381. doi: 10.1111/jce.16440. Epub 2024 Oct 8. J Cardiovasc Electrophysiol. 2024. PMID: 39377569 Free PMC article. Clinical Trial.
-
Safety and Feasibility of Subcutaneous Purse-String Suture of the Femoral Vein After Electrophysiological Procedures on Uninterrupted Oral Anticoagulation.Am J Cardiol. 2017 Jun 1;119(11):1781-1784. doi: 10.1016/j.amjcard.2017.03.006. Epub 2017 Mar 16. Am J Cardiol. 2017. PMID: 28420481 Clinical Trial.
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter.Can J Cardiol. 2011 Jan-Feb;27(1):60-6. doi: 10.1016/j.cjca.2010.11.011. Can J Cardiol. 2011. PMID: 21329863
-
[Catheter ablation of atrial flutter and paroxysmal atrial fibrillation].Arch Cardiol Mex. 2003 Apr-Jun;73 Suppl 1:S88-92. Arch Cardiol Mex. 2003. PMID: 12966653 Review. Spanish.
Cited by
-
A Novel Suture-Based Vascular Closure Device to Achieve Hemostasis after Venous or Arterial Access While Leaving Nothing behind: A Review of the Technological Assessment and Early Clinical Outcomes.J Clin Med. 2024 Aug 7;13(16):4606. doi: 10.3390/jcm13164606. J Clin Med. 2024. PMID: 39200748 Free PMC article. Review.
References
-
- Al-Ahmad A, Mittal S, DeLurgio D, et al. Results from the prospective, multicenter AMBULATE-CAP trial: reduced use of urinary catheters and protamine with hemostasis via the mid-bore venous vascular closure system (VASCADE(R) MVP) following multi-access cardiac ablation procedures. J Cardiovasc Electrophysiol. 2021;32:191–9. 10.1111/jce.14828 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical